To effectively manage compliance risks, Hansoh Pharma has established a comprehensive standardized process for risk assessment and supervision. This process manages risks across the full cycle and departments, including risk identification, risk assessment, formulation of mitigation measures, and supervision and improvement. In terms of policy advocacy, we have achieved full coverage across R&D, manufacturing, and commercial promotion through the development, design, and systematic establishment of multiple institutional frameworks.

We have built a compliance team that understands compliance, knows the business, and upholds the bottom line, while establishing an industry-leading compliance system. This continuously reinforces and reminds every employee of compliance boundaries, enhancing company-wide awareness and accountability in compliance management.

We have built a three-dimensional regulatory system to prevent and control compliance risks, ensuring that management requirements are effectively implemented. By strengthening process control and introducing a dual mechanism of AI-based intelligent technology and third-party oversight, we ensure effective supervision of all operational stages. Our professional compliance team is able to promptly detect and correct violations and mitigate potential legal risks, safeguarding the company’s sustainable development.

Through real-time and visualized compliance management, combined with digitalization and emerging AI technologies, we have effectively reduced compliance risks.

Hansoh Pharma has established an open reporting channel—the Compliance Hotline—and protects whistleblowers’ rights in accordance with the Whistleblowing and Whistleblower Protection Policy. If you discover or suspect any compliance issues involving our employees in business activities, you may report them through the following channels: